Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Melanoma 5Prostatic Neoplasms 3Neuroblastoma 3Neoplasm Metastasis 3Myelodysplastic Syndromes 3Multiple Myeloma 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Breast Neoplasms 3Brain Neoplasms 3Uveal Melanoma 2Pancreatic Neoplasms 2Osteosarcoma 2Oligodendroglioma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Leukemia 2Glioma 2Carcinoma, Renal Cell 2Astrocytoma 2Sarcoma 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Plasma Cell 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Myelomonocytic, Acute 1

Interventions

Temozolomide 93Radiotherapy 66Bevacizumab 35Radiation 22Carmustine 21Erlotinib Hydrochloride 17Chemotherapy, Adjuvant 17Irinotecan 16Magnetic Resonance Spectroscopy 13Radiotherapy, Conformal 11O(6)-benzylguanine 11Surgical Procedures, Operative 10Radiotherapy, Intensity-Modulated 10sargramostim 9Sirolimus 9Imatinib Mesylate 9Carboplatin 9temsirolimus 8motexafin gadolinium 7Thalidomide 7Gene Expression Profiling 7aldesleukin 6Sorafenib 6Radiosurgery 6Immunohistochemistry 6Hydroxyurea 6Gefitinib 6Filgrastim 6Everolimus 6Etoposide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gliosarcoma × Colony-Stimulating Factors × Clear all
NCT01250470 2017-02-27

Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

Roswell Park Cancer Institute

Phase 1 Completed
9 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡